Pages
Products

pLP/VSVG

For research use only. Not intended for any clinical use.
Cat.No.
OVT2806
Host Cell
Mammalian cells, Escherichia coli
Product Type
Vector
Promoter
CMV
Resistance
Ampicillin
Vector Size
5821 bp

Background

Case Study

Applications

Publications

Q & A

Customer Reviews

The pLP/VSVG vector is a lentiviral packaging plasmid explicitly designed for the expression of the vesicular stomatitis virus G glycoprotein. Vesicular stomatitis virus (VSV) is a complex virus that has a broad range of hosts and is instrumental for various applications in virology. Its glycoprotein, specifically the G glycoprotein, plays an essential role in the virus' life cycle, particularly in virus attachment and penetration. Hence, the pLP/VSVG vector facilitates the study and manipulation of this viral component. The pLP/VSVG vector has a length of 5821 base pairs (bp). It confers Ampicillin resistance, which greatly aids in the selection and maintenance of transformed cells in bacterial cultures. One of the key features of the pLP/VSVG vector is its uses as a viral expression and packaging vector. This implies that it can be used not only to express the G glycoprotein of VSV but also to package the resulting gene product into a viral particle. This packaging and expression capacity, combined with the specific gene of interest, makes this vector a valuable tool for myriad research endeavors and broadens its applicability in virology and related fields.

Here, researchers explored the regulatory mechanism of miR-10b on epithelial-mesenchymal transition (EMT) and its impact on the proliferation and migration of nasopharyngeal carcinoma cells. RT-qPCR detected the expression of miR-10b in nasopharyngeal carcinoma cell CNE1. The NP69 nasopharyngeal mucosal cell line was used to determine the expression of miR-10b after lentivirus infection. Studies have shown that miR-10b is highly expressed in CNE1 cells. The stable expression of miR-10b promotes the proliferation and migration of NP69 cells, downregulates the expression of epithelial cell markers E-cadherin and β-catenin, and upregulates the expression of mesenchymal cell markers fibronectin, N-cadherin, vimentin and MMP-9 resulting in cell EMT. Therefore, miR-10b can promote the proliferation and migration of nasopharyngeal carcinoma cells and induce EMT in nasopharyngeal carcinoma cells, which may become a new target for the treatment of nasopharyngeal carcinoma.

In this study, lentivirus-miR-10b infected NP69 cells. Construction of a lentiviral system expressing miR-10b. The sequence of miR-10b was inserted into the lentiviral plasmid pLP/VSVG. pLP/VSVG-miR-10b, pLP1 and pLP2 were co-transfected into 293 T cells, and the supernatant containing lentivirus was collected after 48 hours. NP69 cells were seeded in a 6-well plate, cultured overnight into a monolayer, and then incubated with lentivirus supernatant for 24 hours to allow lentivirus to infect the cells. Lentivirus-infected cells were collected on the day of infection and 2 to 6 days after infection, and RT-qPCR was used to detect the expression level of miR-10b. NP69 cells infected with blank pLP/VSVG were used as control.

Expression level of miR-10b after lentivirus infection of NP69 cells. RT-qPCR was used to detect the expression level of miR-10b on days 1, 2, 3, 4, 5, and 6 after lentivirus infection of NP69 cells. Blank pLP/VSVG is a virus-free control.Figure 1. Expression level of miR-10b after lentivirus infection of NP69 cells. RT-qPCR was used to detect the expression level of miR-10b on days 1, 2, 3, 4, 5, and 6 after lentivirus infection of NP69 cells. Blank pLP/VSVG is a virus-free control. (Wang W. 2017)

The pLP/VSVG vector is a potent tool in the realm of molecular biology, promising vast potential for the research and clinical treatment of various diseases. Essentially, it is a lentiviral packaging plasmid designed to express the vesicular stomatitis virus G (VSVG) glycoprotein. Lentiviral vectors such as pLP/VSVG have been indispensable for the propagation of virus particles in the host cells. They have been increasingly employed in gene therapy because of their appealing capacity to carry and express genes in both dividing and non-dividing cells of practically any mammalian cell type. They have also demonstrated the intriguing ability to stably integrate the conveyed genetic material into the genome of the transduced cells, warranting long-term gene expression and hence, a lasting therapeutic effect. In addition to gene therapy, the pLP/VSVG vector has also found its way into vaccine development. It can be used for delivering immunogenic genes into cells to raise a potent immune response against pathogens such as HIV. It is also instrumental in research areas such as studying gene functions, creating disease models, and stem-cell-based therapies. Moreover, the pLP/VSVG vector is well-suited for pseudotyping lentiviral vectors. In this context, the VSVG protein enhances the virions' stability and broadens their host range, thus permitting the use of lentiviral vectors in a wide array of cell types, both in vitro and in vivo.
Customer Q&As
What is pLP/VSVG?

A: pLP/VSVG is a lentiviral packaging plasmid for expression of the vesicular stomatitis virus G glycoprotein.

What are the main components provided by pLP/VSVG?

A: The pLP/VSVG supplies helper functions, structural proteins, and replication proteins essential for lentivirus production.

What is VSV G envelope protein?

A: The VSV G envelope protein refers to the glycoprotein found on the surface of the Vesicular Stomatitis Virus (VSV). It plays a crucial role in the viral lifecycle as it helps the virus attach and enter host cells.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Reliable and efficient

I have used the pLP/VSVG vector in my research and found it to be reliable and efficient in both in vitro and in vivo experiments.

United Kingdom

01/04/2024

Easy to handle

The pLP/VSVG vector is highly efficient for transfecting mammalian cells, producing a significant amount of virions, and is generally easier to handle compared to other viral vectors.

United Kingdom

05/04/2020

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Quick Inquiry

Inquiry